- Featured Product
- KD/KO Validated
AlaRS Monoklonaler Antikörper
AlaRS Monoklonal Antikörper für WB, IF/ICC, IF-P, Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IF/ICC, IF-P, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1C8H3
Kat-Nr. : 67909-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
67909-1-PBS bindet in WB, IF/ICC, IF-P, Indirect ELISA AlaRS und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | AlaRS fusion protein Ag11151 |
| Vollständiger Name | alanyl-tRNA synthetase |
| Berechnetes Molekulargewicht | 968 aa, 107 kDa |
| Beobachtetes Molekulargewicht | 107 kDa |
| GenBank-Zugangsnummer | BC011451 |
| Gene symbol | AlaRS |
| Gene ID (NCBI) | 16 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
AARS(alanyl-tRNA synthetase) is also named as AlaRS(alanine tRNA ligase 1, cytoplasmic), renal carcinoma antigen NY-REN-42 and belongs to the class-II aminoacyl-tRNA synthetase family. It can interpret the RNA code and attach specific aminoacids to the tRNAs that contain the cognate trinucleotide anticodons. AARS consists of three domains: the N-terminal catalytic domain, the editing domain and the C-terminal C-Ala domain. The editing domain removes incorrectly charged amino acids, while the C-Ala domain, along with tRNA(Ala), serves as a bridge to cooperatively bring together the editing and aminoacylation centers thus stimulating deacylation of misacylated tRNAs(PMID:19661429).













